Immune checkpoint inhibitor‐induced vitiligo: A large‐scale real world pharmacovigilance study

Documenti analoghi

• Pharmacovigilance Insights Into Immune Checkpoint Inhibitor‐Induced Risk of Paraneoplastic Syndrome: A Large‐Scale Real World Study
  di: Bufu Tang, et al.
  Pubblicazione: (2026)
• Decoding fatal toxic effects in checkpoint inhibitor therapy using real‐world pharmacovigilance data and machine learning
  di: Dongxue Yan, et al.
  Pubblicazione: (2025)
• Melanosis and isolated follicular vitiligo during checkpoint inhibitors for metastatic melanoma
  di: Valentine Salvestrini, et al.
  Pubblicazione: (2024)
• Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives
  di: Nozomu Yanaihara, et al.
  Pubblicazione: (2025)
• Efficacy and safety of bronchial arterial infusion chemotherapy combined with transarterial chemoembolization and systemic therapy in hepatocellular carcinoma patients with lung metastases
  di: Caihong Yu, et al.
  Pubblicazione: (2026)